Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
173
days
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy
Authors
Mar Iglesias Coma; Jordi Badia-Ramentol; Carolina Martinez-Ciarpaglini; Jenniffer Linares; Noelia Tarazona; Nuria Mulet-Margalef; Paula Tornero-Piñero; Anna Sallent-Aragay; Alba Recort-Bascuas; Joan Gibert; Marta Sant-Albors; Daniele V F Tauriello; Melba Cruz-Moral; Marina Carreras-Gallardo; Elena Sancho; Clara Morral Martinez; Marta Garrido; Jose Luis Manzano Mozo; Andrés Cervantes; Clara Montagut; Eduard Batlle; Alexandre CalonShow moreShow less
Affiliations
1. Department of Pathology, Hospital del Mar, Barcelona, Spain; 2. Cancer Research Program, Hospital del Mar Research Institute (HMRIB), Barcelona, Spain; 3. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; 4. Department of Pathology, Hospital Clínico Universitario, University of Valencia, Valencia, Spain; 5. INCLIVA Biomedical Research Institute, Valencia, Spain; 6. Department of Medical Oncology, Hospital del Mar, Barcelona, Spain; 7. Department of Medical Oncology, Hospital Clinico Universitario, University of Valencia, Valencia, Spain; 8. Department of Medical Oncology, Catalan Institute of Oncology (ICO) Badalona, Badalona, Spain; 9. Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain; 10. Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; 11. Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; 12. Pompeu Fabra University, Barcelona, Spain; 13. Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, SpainShow moreShow less
111
days
Commonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case–control study
Authors
Annelies Boven; Harry Vranken; Erika Vlieghe; Annemarie Boleij; Katja Fall; Lars Engstrand; Nele BrusselaersShow moreShow less
Affiliations
1. Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; 2. Global Health Institute, Department of Family Medicine and Population Health, Antwerp University, Antwerp, Belgium; 3. Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands; 4. School of Health and Medical Sciences, Örebro University, Örebro, Sweden; 5. Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden; 6. Department of Public Health and Primary Care, Ghent University, Ghent, BelgiumShow moreShow less
76
days
Gut microbiome signatures in colorectal neoplasia: a cross-sectional study across neoplasia stages and subtypes
Authors
Panayiotis Louca; Sarah Manning; Eleanor Hackney; Linda Sharp; Mark A Hull; Sara Koo; Gregory R Young; Guy S Taylor; Yashvee Dunneram; Suparna Mitra; James S Hampton; Christina Dobson; Laura J Neilson; Caroline Addison; Emad M El-Omar; the COLO-COHORT research teamGallonRichardEmmersonIngridLivingstoneClaireBurnsAmyGrahamMarkBestwickNathaniaPeaslandAmyGhouriAamarWhelptonJohnVermaAjayWallisKatharinaRaiSajalLeeTomJohnstonMatthewAfsharSorenaGreenawayJohnLouis-AugusteJohnDayAndrewCanoyMarkConlinAbbyHellierSimonFarrellIanBevanRosinMougSusanGeraghtyJoeMohammedNooMountfordChrisPrudhamRogerTuttonMatthewMalikAliThoufeeqMoMehtaShameerSebastianSDentKathy; Christopher J Stewart; Colin J ReesShow moreShow less
Affiliations
1. Human Nutrition & Exercise Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle University, Newcastle upon Tyne, UK; 2. Department of Gastroenterology, South Tyneside and Sunderland NHS Foundation Trust, South Tyneside District Hospital, South Tyneside and Sunderland NHS Foundation Trust, South Shields, UK; 3. Population Health Sciences Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK; 4. Leeds Institute of Medical Research, University of Leeds, St James’s University Hospital, Leeds, UK; 5. Translational and Clinical Research Institute, Newcastle University, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK; 6. North East Hub, Bowel Cancer Screening Programme, Gateshead, UK; 7. Microbiome Research Centre, St George & Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales, Sydney, New South Wales, AustraliaShow moreShow less
199
days
MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating mitochondrial metabolism reprogramming
Authors
Yang Chen; Gao-Wei Jin; Li-Hong He; Yu Dong; Yan-Na Zhang; Han-Xiang Guo; Yi-Ting Xu; Zi-Yang Wei; Bin-Fei Dang; Chun-Yang Mu; Wan-Yue Cao; Yi-Ze Zhang; Xiao-Bao Wei; Yu-Xiong Feng; Yun-Hua Liu; Qi Zhang; Ting-Bo LiangShow moreShow less
Affiliations
1. Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; 2. Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; 3. MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; 4. Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China; 5. Department of Pathology & Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China; 6. Cancer Center, Zhejiang University, Hangzhou, ChinaShow moreShow less
174
days
Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition
Authors
Di Wu; Chunbin Zhu; Haoqi Pan; He Xu; Jin Xu; Yang Liu; Sikai Wang; Mingming Xiao; Xianjun Yu; Si ShiShow moreShow less
Affiliations
1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Shanghai Pancreatic Cancer Institute, Shanghai, China; 4. Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China; 5. Pancreatic Cancer Institute, Fudan University, Shanghai, China; 6. School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA, Buffalo, New York, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days